Elicio Therapeutics, Inc. reports

Company location: Boston, MA
Fiscal year end: 31 December

Elicio Therapeutics, Inc. has filed 381 SEC EDGAR filings since 04 Mar 2014

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 326-350 of 381 matching filings.

Per page

25

Current page

14

4

FORM 4

Filing date: 10 Mar 2021
Reporting date: 08 Mar 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3/A

FORM 3/A

Filing date: 19 Feb 2021
Reporting date: 04 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 17 Feb 2021
Reporting date: 13 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 11 Feb 2021
Reporting date: 09 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 11 Feb 2021
Reporting date: 09 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 11 Feb 2021
Reporting date: 09 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 11 Feb 2021
Reporting date: 09 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 11 Feb 2021
Reporting date: 09 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

S-8 File 333-252906

FORM S-8

Filing date: 09 Feb 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-39990

FORM 8-K

Filing date: 09 Feb 2021
Reporting date: 04 Feb 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4

Filing date: 08 Feb 2021
Reporting date: 04 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 08 Feb 2021
Reporting date: 04 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 08 Feb 2021
Reporting date: 04 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 08 Feb 2021
Reporting date: 04 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

424B4 File 333-252177

424B4

Filing date: 05 Feb 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

EFFECT File 333-252177

EFFECT filing

Filing date: 04 Feb 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3

Filing date: 04 Feb 2021
Reporting date: 04 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3

Filing date: 04 Feb 2021
Reporting date: 04 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3

Filing date: 04 Feb 2021
Reporting date: 04 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3

Filing date: 04 Feb 2021
Reporting date: 04 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3

Filing date: 04 Feb 2021
Reporting date: 04 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3

Filing date: 04 Feb 2021
Reporting date: 04 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3

Filing date: 04 Feb 2021
Reporting date: 04 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3

Filing date: 04 Feb 2021
Reporting date: 04 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3

Filing date: 04 Feb 2021
Reporting date: 04 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .